|
DB-1305/BNT325 Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since May 2026
Also known as: DB-1305/BNT325 for Injection
Pipeline
Phase 2: 1
Top Sponsors
- DualityBio Inc.1
Indications
- Liver Disease1
- Solid Tumors1
- Liver Cancer1
- Lung Cancer1
- Cancer1
Los Angeles, California1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.